<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:hpo ids='HP_0011009'>Acute</z:hpo> <z:chebi fb="0" ids="3347">Candesartan</z:chebi> Cilexetil Therapy in <z:hpo ids='HP_0001297'>Stroke</z:hpo> Survivors (ACCESS) study indicated that early treatment with an angiotensin type 1 receptor blocker in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients who had relatively <z:mp ids='MP_0002842'>high blood pressure</z:mp> improved <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality in the <z:hpo ids='HP_0011010'>chronic</z:hpo> stage </plain></SENT>
<SENT sid="1" pm="."><plain>To better interpret the findings of this study, we determined whether <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with high <z:hpo ids='HP_0011009'>acute</z:hpo> blood pressure had specific underlying conditions </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We divided 712 consecutive patients who were hospitalized within 48 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> into two groups: 77 patients with high <z:hpo ids='HP_0011009'>acute</z:hpo> blood pressure that met the criteria of the ACCESS study and the 635 remaining patients </plain></SENT>
<SENT sid="3" pm="."><plain>Underlying risk factors and comorbidities, <z:hpo ids='HP_0001297'>stroke</z:hpo> characteristics, as well as mortality, vascular events, and disability at 3 weeks were compared between the two groups </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Patients with high <z:hpo ids='HP_0011009'>acute</z:hpo> blood pressure more frequently had <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (p &lt; 0.01), intracranial <z:hpo ids='HP_0100545'>arterial stenosis</z:hpo> (p &lt; 0.02), higher levels of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A1c (p &lt; 0.005), higher <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels (p &lt; 0.005), and tended to more frequently have <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (p &lt; 0.09) and <z:mpath ids='MPATH_124'>infarcts</z:mpath> &lt;1.5 cm in diameter (p &lt; 0.09) than the other patients </plain></SENT>
<SENT sid="5" pm="."><plain>On multivariate analysis, high levels of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A1c, high <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels, and intracranial <z:hpo ids='HP_0100545'>arterial stenosis</z:hpo> were independently predictive of high <z:hpo ids='HP_0011009'>acute</z:hpo> blood pressure </plain></SENT>
<SENT sid="6" pm="."><plain>At 3 weeks after the <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo>, patients with high <z:hpo ids='HP_0011009'>acute</z:hpo> blood pressure were more dependent in their daily living activities (p &lt; 0.02) and more frequently developed vascular events or <z:hpo ids='HP_0011420'>death</z:hpo> (p &lt; 0.005) than the other patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Poorly controlled <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and advanced renal damage appeared to correlate with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000822'>hypertension</z:hpo> after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Since intracranial <z:hpo ids='HP_0100545'>arterial stenosis</z:hpo> also seemed to contribute to high <z:hpo ids='HP_0011009'>acute</z:hpo> blood pressure, one should be careful not to induce <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> by the early use of <z:chebi fb="0" ids="35674">antihypertensives</z:chebi> </plain></SENT>
</text></document>